Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Cidara Thera
(NQ:
CDTX
)
2.310
USD
-0.030 (-1.28%)
Official Closing Price
Updated: 6:30 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Cidara Thera
< Previous
1
2
3
4
5
Next >
Cidara Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
March 03, 2021
From
GlobeNewswire News Releases
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
February 25, 2021
From
GlobeNewswire News Releases
UTILITY Therapeutics Joins Antimicrobials Working Group
February 17, 2021
The Antimicrobials Working Group (AWG) announced today the addition of UTILITY therapeutics Ltd. (UTILITY) to its coalition of companies with the mission to combat drug resistant infections and spur...
From
PR Newswire
Cidara Therapeutics Announces New Data for Rezafungin at the 21st ICHS Symposium
February 17, 2021
New analyses from completed Phase 2 STRIVE trial support once-weekly, long-acting rezafungin for the treatment of candidemia and invasive candidiasis in high-risk patient populations
From
GlobeNewswire News Releases
Cidara Therapeutics to Present New Data for Rezafungin and Influenza AVCs at the 21st ICHS Symposium
February 11, 2021
From
GlobeNewswire News Releases
Cidara Therapeutics Announces Key Additions to its Board of Directors
January 25, 2021
From
GlobeNewswire News Releases
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 05, 2021
From
GlobeNewswire News Releases
Cidara Therapeutics Appoints Biotechnology Industry Veteran Christopher Kurtz As Executive Vice President of Technical Operations
December 15, 2020
Former head of commercial API manufacturing at Gilead Sciences will lead technical operations for development of Cidara’s antifungal and antiviral programs
From
GlobeNewswire News Releases
Cidara Therapeutics to Present Preclinical Data for Influenza AVCs at the 7th ESWI Influenza Conference
December 01, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics to Present New Clinical Data for Rezafungin at ESICM LIVES 2020
November 30, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics Named a San Diego Metro Area Top Workplace for the Fourth Consecutive Year
November 16, 2020
Employee feedback places Cidara among top 20 small companies in the area
From
GlobeNewswire News Releases
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
November 11, 2020
From
GlobeNewswire News Releases
Cidara Provides Corporate Update and Reports Third Quarter 2020 Financial Results
November 05, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCs at IDWeek 2020
October 21, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics to Present at the 2020 American College of Clinical Pharmacy (ACCP) Annual Meeting
October 13, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics to Present New Clinical and Preclinical Data for Rezafungin and Influenza AVCs at IDWeek 2020
September 14, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics to Participate in Upcoming Investor Conferences
September 02, 2020
From
GlobeNewswire News Releases
Cidara Provides Corporate Update and Reports Second Quarter 2020 Financial Results
August 13, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
August 04, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics Announces Formation of Scientific Advisory Board
July 27, 2020
Comprised of World-Renowned Experts in Virology, Fungal Diseases and Hematology
From
GlobeNewswire News Releases
Cidara Therapeutics to Participate in B. Riley Virtual Summer Series Panel on Antiviral Therapeutics
July 17, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics Added to Russell 3000® Index
June 29, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics to Participate in Cantor Fitzgerald Virtual Symposium: Winning Ways to Treat Infections and COVID-19
June 23, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics to Present at the Raymond James Human Health Innovations Conference
June 11, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation
May 20, 2020
From
GlobeNewswire News Releases
Cidara Provides Corporate Update and Reports First Quarter 2020 Financial Results
May 13, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCs from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
May 05, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics to Participate in Antifungal and COVID-19 Therapeutics Panels at Maxim Group’s Infectious Disease Virtual Conference
April 28, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
April 07, 2020
From
GlobeNewswire News Releases
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
March 04, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.